Performance evaluation of novel fluorescent-based lateral flow immunoassay (LFIA) for rapid detection and quantification of total anti-SARS-CoV-2 S-RBD binding antibodies in infected individuals.
- DOI
- 10.1016/j.ijid.2022.02.052
- Published
- 2022 May
- Container
- International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ijid.2022.02.052,
title = {Performance evaluation of novel fluorescent-based lateral flow immunoassay (LFIA) for rapid detection and quantification of total anti-SARS-CoV-2 S-RBD binding antibodies in infected individuals.},
author = {Shurrab FM and Younes N and Al-Sadeq DW and Liu N and Qotba H and Abu-Raddad LJ and Nasrallah GK},
year = {2022},
journal = {International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases},
doi = {10.1016/j.ijid.2022.02.052},
url = {https://doi.org/10.1016/j.ijid.2022.02.052}
}RIS
TY - JOUR TI - Performance evaluation of novel fluorescent-based lateral flow immunoassay (LFIA) for rapid detection and quantification of total anti-SARS-CoV-2 S-RBD binding antibodies in infected individuals. AU - Shurrab FM AU - Younes N AU - Al-Sadeq DW AU - Liu N AU - Qotba H AU - Abu-Raddad LJ AU - Nasrallah GK PY - 2022 JO - International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases DO - 10.1016/j.ijid.2022.02.052 UR - https://doi.org/10.1016/j.ijid.2022.02.052 ER -
APA
FM, S., N, Y., DW, A., N, L., H, Q., LJ, A., & GK, N. (2022). Performance evaluation of novel fluorescent-based lateral flow immunoassay (LFIA) for rapid detection and quantification of total anti-SARS-CoV-2 S-RBD binding antibodies in infected individuals.. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. https://doi.org/10.1016/j.ijid.2022.02.052
Source records
- pubmed · retrieved 2026-09-26T18:44:06.231Z